🇺🇸 BETA CAROTENE in United States

1,925 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 225 reports (11.69%)
  2. Off Label Use — 208 reports (10.81%)
  3. Vomiting — 203 reports (10.55%)
  4. Hyponatraemia — 197 reports (10.23%)
  5. Constipation — 187 reports (9.71%)
  6. General Physical Health Deterioration — 185 reports (9.61%)
  7. Stress — 184 reports (9.56%)
  8. Multiple Organ Dysfunction Syndrome — 180 reports (9.35%)
  9. Sepsis — 180 reports (9.35%)
  10. Abdominal Distension — 176 reports (9.14%)

Source database →

BETA CAROTENE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is BETA CAROTENE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for BETA CAROTENE in United States?

Marketing authorisation holder not available in our data.